China Jo-Jo Drugstores Stock (NASDAQ:CJJD)


RevenueOwnershipFinancialsChart

Previous Close

$1.97

52W Range

$1.34 - $5.20

50D Avg

$1.90

200D Avg

$2.79

Market Cap

$13.91M

Avg Vol (3M)

$13.74K

Beta

-0.02

Div Yield

-

CJJD Company Profile


China Jo-Jo Drugstores, Inc., together with its subsidiaries, operates as a retailer and distributor of pharmaceutical and other healthcare products in the People's Republic of China. The company operates through four segments: Retail Drugstores, Online Pharmacy, Drug Wholesale, and Herb Farming. Its stores provide various pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines (TCM), personal and family care products, and medical devices, as well as convenience products, such as consumable, seasonal, and promotional items. The company also operates licensed doctors of Western medicine and TCM on site for consultation, examination, and treatment of common ailments at scheduled hours. In addition, it operates online drugstore that retails OTC drugs and nutritional supplements, as well as sells products through third-party platforms. Further, the company distributes third-party pharmaceutical products primarily to trading companies, as well as cultivates and wholesales herbs used for TCM. As of March 31, 2021, it had 109 retail pharmacies under the Jiuzhou Grand Pharmacy name, as well as 4 drugstores. The company was founded in 2003 and is headquartered in Hangzhou, the People's Republic of China.

Show More

Industry

Medical - Pharmaceuticals

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

CN

Employees

939

IPO Date

Oct 01, 2009

Website

CJJD Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceMar 22
DrugWholesaleMember$164.51K
OnlinePharmacyMember$3.81M
RetailDrugstoresMember$3.50M
WholesaleMember$164.51K

Fiscal year ends in Mar 23 | Currency in USD

CJJD Financial Summary


Mar 23Mar 22Mar 21
Revenue$148.81M$164.39M$133.13M
Operating Income$-10.57M$-2.55M$-8.61M
Net Income$-21.14M$-3.20M$-8.38M
EBITDA$-7.28M$-431.14K$-5.97M
Basic EPS$-41.46$-220.62$-49.29
Diluted EPS$-41.46$-220.62$-49.29

Fiscal year ends in Mar 23 | Currency in USD

Latest Earnings Call Transcripts


Q2 14Nov 15, 13 | 3:52 PM
Q1 14Aug 19, 13 | 10:11 AM

Peer Comparison


TickerCompany
MDVLMedAvail Holdings, Inc.
PETSPetMed Express, Inc.
BIMIBIMI International Medical Inc.
LFLYLeafly Holdings, Inc.
WBAWalgreens Boots Alliance, Inc.
HITIHigh Tide Inc.
YI111, Inc.
RADRite Aid Corporation
MEDSTRxADE HEALTH, Inc.